Welcome Guest | Register / Login

Biotechnology Market Research Reports

Bio-technology is an ingenious fusion of bio-science and technology for unearthing possibilities in health care and farming. Although bio-technology is relatively a modern concept, it has enabled researchers look at the world of life-sciences from a different perspective; in fact, some of the traditionally held beliefs have either been proven wrong or differently established. As a consequence, the twin-world of medical and agriculture science has been able to understand and map solutions for better health care quality and agricultural produce.
Due to its in... View more
Sort By
Title Published Price Buy Now
Autophagy modulators -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Autophagy modulators-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Autophagy modulators. The DelveInsight's Report covers the product profiles in various...
Jan 2017 $ 1250
Fibroblast activation protein (FAP) antagonists -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Fibroblast activation protein (FAP) antagonists-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Fibroblast activation protein (FAP) antagonists. The DelveI...
Jan 2017 $ 1250
Ubiquitin conjugating enzyme inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Ubiquitin conjugating enzyme inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Ubiquitin conjugating enzyme inhibitors. The DelveInsight's Report ...
Jan 2017 $ 1250
Isocitrate Dehydrogenase (IDH1) inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Isocitrate Dehydrogenase (IDH1) inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Isocitrate Dehydrogenase (IDH1) inhibitors. The DelveInsight's R...
Jan 2017 $ 1250
Enhancer of zeste homolog 2 (EZH2) inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Enhancer of zeste homolog 2 (EZH2) inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Enhancer of zeste homolog 2 (EZH2) inhibitors. The DelveInsig...
Jan 2017 $ 1250
RET (Ret Proto-Oncogene) protein inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "RET (Ret Proto-Oncogene) protein inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the RET (Ret Proto-Oncogene) protein inhibitors. The DelveInsight's...
Jan 2017 $ 1250
Tankyrase PARP5A (poly(ADP-ribosyl)transferase 5a) Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Tankyrase PARP5A (poly(ADP-ribosyl)transferase 5a) Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Tankyrase PARP5A (poly(ADP-ribosyl)transferas...
Jan 2017 $ 1250
BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the BRAFV600 mutation (B-Raf prot...
Jan 2017 $ 1250
Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Yes Tyrosine Kinase Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Yes Tyrosine Kinase Inhibitors. The DelveInsight's Report covers the product...
Jan 2017 $ 1250
Xanthine Oxidase Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Xanthine Oxidase Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Xanthine Oxidase Inhibitors. The DelveInsight's Report covers the product profi...
Jan 2017 $ 1250
Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Wnt Signaling Pathway Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Wnt Signaling Pathway Inhibitors. The DelveInsight's Report covers the pro...
Jan 2017 $ 1250
Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Wee1 Tyrosine Kinase inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Wee1 Tyrosine Kinase inhibitors. The DelveInsight's Report covers the produ...
Jan 2017 $ 1250
Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent T-Type Calcium Channel Blockers. The De...
Jan 2017 $ 1250
Voltage-Dependent N-Type Calcium Channel Blockers -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Voltage-Dependent N-Type Calcium Channel Blockers-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent N-Type Calcium Channel Blockers. The De...
Jan 2017 $ 1250
Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Voltage-Dependent Calcium Channel Blockers-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent Calcium Channel Blockers. The DelveInsight's R...
Jan 2017 $ 1250
Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent Calcium Channel Alpha-2/Delta Bl...
Jan 2017 $ 1250
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vitamin D Receptor (VDR or Calcitriol Receptor) Agonists-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vitamin D Receptor (VDR or Calcitriol Receptor) Ag...
Jan 2017 $ 1250
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Viral RNA Polymerase Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Viral RNA Polymerase Inhibitors. The DelveInsight's Report covers the produ...
Jan 2017 $ 1250
Viral DNA Polymerase Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Viral DNA Polymerase Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Viral DNA Polymerase Inhibitors. The DelveInsight's Report covers the produ...
Jan 2017 $ 1250
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the VCAM-1 (vascular cell adhesion molecul...
Jan 2017 $ 1250
Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2 ) Agonists-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vasoactive Intestinal Polypeptide Receptor 2...
Jan 2017 $ 1250
Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor D (VEGF-D) Inhi...
Jan 2017 $ 1250
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor C (VEGF-C) Inhi...
Jan 2017 $ 1250
Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vascular Endothelial Growth Factor B (VEGF-B) Inhibitors-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor B (VEGF-B) Inhi...
Jan 2017 $ 1250
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights, 2017
By Delve Insight
DelveInsight's, "Vascular Endothelial Growth Factor A (VEGF-A) Activator-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor A (VEGF-A) Activ...
Jan 2017 $ 1250